L707-1265 Screening compound: 7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

L707-1265 Screening compound: 7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one
L707-1265 Screening compound: 7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-1265
7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-1265

Molecular Formula

C25H29N3O5S (C25 H29 N3 O5 S)

Compound Name

7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

IUPAC name

7-(morpholine-4-sulfonyl)-1-[2-oxo-2-(1234-tetrahydroisoquinolin-2-yl)ethyl]-2345-tetrahydro-1H-1-benzazepin-2-one

SMILES

O=C(CN(c(cc1)c(CCC2)cc1S(N1CCOCC1)(=O)=O)C2=O)N(CC1)Cc2c1cccc2

InChI

InChI=1S/C25H29N3O5S/c29-24-7-3-6-20-16-22(34(31,32)27-12-14-33-15-13-27)8-9-23(20)28(24)18-25(30)26-11-10-19-4-1-2-5-21(19)17-26/h1-2,4-5,8-9,16H,3,6-7,10-15,17-18H2

InChI Key

LTGPLMGDRVGZRD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27472063

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.558

Distribution Coefficient, logD

2.558

Water Solubility, LogSw

-2.94

Polar Surface Area

71.624

Acid Dissociation Constant (pKa)

22.17

Base Dissociation Constant (pKb)

-2.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

L707-1265 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

CNS MPO Library (28609 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L707-1265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-1265?
Check Price and Availability of L707-1265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-1265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-1265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-1265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-1265 available by request